The Pharmaceuticals market shows solid growth, which is mainly driven by innovative drugs and an increasing demand for healthcare, especially in emerging countries. Compared to the revenue generated by prescription drugs, OTC pharmaceuticals only play a minor role. The market for prescription drugs, for its part, is dominated by original products. This means that the larger number of OTC products, generics, and biosimilars sold cannot counterbalance the significantly higher prices of original products.
Select Advertising M&A Transactions
Exitwise has catalogued the most relevant M&A transactions that our industry specialized, M&A experts have completed. Feel free to search through our transaction catalogue, or better yet,Contact Usto request a list of the most relevant exits from your industry.
BioElectron develops therapeutic treatments for inherited mitochondrial diseases primarily affecting children.
Entasis is focused on the discovery, development, and commercialization of targeted antibacterial products that address high unmet medical needs to treat serious infections caused by multidrug-resistant pathogens.
Serenity Pharmaceuticals is focused on developing products that address urinary conditions that impact the health and well-being of millions of people. Serenity Pharmaceuticals is working to develop patented pharmaceuticals with unique delivery mechanisms and formulations, to provide safe and effective treatments for voiding disorders.